TEVAR与单纯优化药物治疗非复杂性B型主动脉夹层的系统评价与Meta分析
该系统评价与Meta分析比较了TEVAR联合优化药物治疗与单纯优化药物治疗非复杂性B型主动脉夹层(unTBAD)的短期和长期结局。共纳入25,650例患者(OMT组21,041例,TEVAR组4,609例)。汇总分析显示30天及院内死亡率无显著差异(log OR 0.1058,P=0.4971),但随机效应模型显示log OR为-1.3696,OR为0.2542(P<0.0001)。结论认为TEVAR对unTBAD的作用仍有争议,虽可改善主动脉重塑,但无确切证据表明提高生存率。
要点
- 共纳入25,650例unTBAD患者,OMT组21,041例,TEVAR组4,609例。
- 30天及院内死亡率汇总分析无显著差异(log OR 0.1058,P=0.4971)。
- 随机效应模型显示OR 0.2542(P<0.0001),生存率TEVAR组高于OMT组。
核心结论
- TEVAR在unTBAD管理中的作用仍有争议,研究显示TEVAR后主动脉重塑改善,但无确切证据表明提高生存率。
- 需要开展随机试验并制定包含高危特征的指南来评估这一复杂患者群体。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Ovid、Scopus和EMBASE数据库,比较TEVAR与OMT治疗unTBAD的长期结局。
- 遵循PICO框架和PRISMA指南制定检索策略,检索限于标题和摘要,并进行引文审查。
- 纳入研究依据严格的纳入和排除标准评估,统计分析使用Jamovi(版本2.5)。
- 分析总患者数25,650例,其中OMT组21,041例,TEVAR组4,609例。
主要发现
- OMT组平均年龄61.7岁,69.7%在急性期(<15天)治疗,平均最大主动脉直径38.5 mm,假腔(FL)直径平均25.4 mm。
- TEVAR组平均年龄59.7岁,76.2%在急性期治疗,平均最大主动脉直径40.2 mm,FL直径平均26.4 mm。
- 汇总分析显示30天及院内死亡率无显著差异(log OR 0.1058,P=0.4971)。
- 随机效应模型显示log OR为-1.3696,OR为0.2542(P<0.0001)。
- 生存率:OMT组95.4% vs TEVAR组98%;1年OMT组90.2%(95%CI 85.7-90.7)vs TEVAR组94%(95%CI 90.6-97.5);2年OMT组71.8%(95%CI 63.4-80.1)vs TEVAR组83.7%(95%CI 75.6-91.8);3年OMT组82.2%(95%CI 77.4-87)vs TEVAR组89.9%(95%CI 86.1-93.7)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This meta-analysis reviewed the outcomes of patients with uncomplicated Type B aortic dissection (unTBAD) treated with either thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy (OMT) or OMT alone. The study evaluated both short-term and long-term outcomes to assess whether TEVAR improved overall mortality and reduced complications such as retrograde type A dissection, stroke, paraplegia, and aortic remodeling. METHODS: We conducted comprehensive searches on PubMed, Ovid, Scopus, and Excerpta Medica Database (EMBASE) to identify studies comparing long-term outcomes of TEVAR and OMT for unTBAD. Using the Population, Intervention, Comparator, and Outcome (PICO) framework and adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we formulated the search query. The search was limited to titles and abstracts and included thorough citation reviews. Each study was evaluated against strict inclusion and exclusion criteria for eligibility. Statistical analysis was performed using Jamovi (Version 2.5) from the Jamovi project (2024). RESULTS: The total number of patients with unTBAD in our analysis was 25,650, with 21,041 receiving optimal medical therapy (OMT) and 4,609 treated with TEVAR. The OMT group had an average age of 61.7 years, with 69.7% treated in the acute phase (<15 days). Their mean maximum aortic diameter was 38.5 mm, and the false lumen (FL) diameter averaged 25.4 mm. In the TEVAR group, the average age was 59.7 years, with 76.2% treated acutely. The average maximum aortic diameter was 40.2 mm, and the FL diameter was 26.4 mm. A pooled analysis showed no significant difference in 30-day and inhospital mortality rates (log odds ratio 0.1058, P = 0.4971). However, a random-effects model indicated a log odds ratio of -1.3696, resulting in an odds ratio of 0.2542 (P < 0.0001). Survival rates were 95.4% for the OMT group and 98% for the TEVAR group. At 1 year, survival was 90.2% for the OMT group (95% confidence interval [CI]: 85.7-90.7) and 94% for the TEVAR group (95% CI: 90.6-97.5). At 2 years, OMT survival was 71.8% (95% CI: 63.4-80.1) compared to 83.7% for TEVAR (95% CI: 75.6-91.8). At 3 years, survival was 82.2% for OMT (95% CI: 77.4-87) and 89.9% for TEVAR (95% CI: 86.1-93.7). CONCLUSION: The role of TEVAR in managing unTBAD remains debated. While studies show improved aortic remodeling post-TEVAR, there is no definitive evidence for increased survival rates. It is essential to conduct randomized trials and develop guidelines that include high-risk features for assessing this complex patient group.
引用
- Jubouri M, Surkhi AO, Alsarayrah AI, et al. TEVAR Versus Optimal Medical Therapy for Uncomplicated Type B Aortic Dissection: A Systematic Review & Meta-analysis. Ann Vasc Surg. 2025. PMID: 40582458. doi:10.1016/j.avsg.2025.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。